Differential methylation of TCF7L2 promoter in peripheral blood DNA in newly diagnosed, drug-naïve patients with type 2 diabetes.
TCF7L2 is the susceptibility gene for Type 2 diabetes (T2D) with the largest effect on disease risk that has been discovered to date. However, the mechanisms by which TCF7L2 contributes to the disease remain largely elusive. In addition, epigenetic mechanisms, such as changes in DNA methylation patt...
Guardado en:
Autores principales: | Silvia Canivell, Elena G Ruano, Antoni Sisó-Almirall, Belchin Kostov, Luis González-de Paz, Eduardo Fernandez-Rebollo, Felicia A Hanzu, Marcelina Párrizas, Anna Novials, Ramon Gomis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c0fc83e670f44068e6edb0cae63a396 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Altered cerebellum functional network on newly diagnosed drug-naïve Parkinson’s disease patients with anxiety
por: Wang Yirong, et al.
Publicado: (2021) -
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3.
por: Maddalena Trombetta, et al.
Publicado: (2012) -
Task to limit the oxidative stress in patients with newly diagnosed type 2 diabetes
por: Yu A Zanozina, et al.
Publicado: (2013) -
Increased Circulating Levels of Ectodysplasin A in Newly Diagnosed Type 2 Diabetic Patients
por: Xia Deng, et al.
Publicado: (2021) -
The Factors Influencing the Renal Glucose Threshold in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Cui SS, et al.
Publicado: (2021)